Concepta Labs, LLC

Concepta Labs, LLC was paid $47K by Medicaid between Dec 2021 and May 2023, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 61% of everything it billed.

33Billing provider infoCONCEPTA LABS, LLC
DALLAS, TX 75244

33aNPI1275046575assigned 11/08/2017

33bProvider typeClinical Medical Laboratory

28Total paid$47K

24GClaims1,868

24DCodes billed4

24AFirst – last monthDec 2021 – May 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#191 of 436

Median peer was paid$17K

This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	84	$3K
2022	1,384	$43K
2023	400	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	61%	492	423	$29K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	19%	490	420	$9K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	18%	486	415	$8K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	2.8%	400	395	$1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMILLER, CHRISTY (MANAGER)

Same official

Other billing entities under MILLER, CHRISTY

Full network →

Provider	Location	Paid
Christy Miller LLC	Yulee, FL	$557K
Miller Family Counseling Services, PLLC	Parker, CO	$20K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.